METHODS TO IMPROVE ANTI-ANGIOGENIC THERAPY AND IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

The General Hospital Corporation

发明人:

Dai Fukumura,Keehoon Jung,Rakesh K. Jain

申请号：

US16628941

公开号：

US20200216549A1

申请日:

2018.07.09

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Agents that inhibit CX3CL1 in endothelial cells to reduce or inhibit immunosuppression mechanisms that are co-opted by cancer cells to evade host immune system, and that reduce immunosuppression in context of therapies that target VEGF-dependent signaling, and methods of use thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/